Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Archives of Internal Medicine

• Publication date

  2000-09-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.160.17.2653PMID 10999980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deaths: final data for 1997.

  1999cited by this paper
• The American health care system--Medicaid.

  1999cited by this paper
• Update : Future Directions for Research on Dmseases of the Lung

  1999cited by this paper
• Geographic variations in utilization rates in Veterans Affairs hospitals and clinics.

  1999cited by this paper
• Use of services by diabetes patients in managed care organizations

  1998cited by this paper
• Risk adjustment or risk avoidance?

  1998cited by this paper
• Risk adjustment: where are we now?

  1998cited by this paper
• Capitation, managed care, and chronic obstructive pulmonary disease.

  1998influential reference
• Use of Services by Diabetes Patients in Managed Care Organizations: Development of a diabetes surveillance system

  1998cited by this paper
• A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.

  1998cited by this paper
• Update: future directions for research on diseases of the lung. The American Thoracic Society.

  1998cited by this paper
• Paying more fairly for Medicare capitated care.

  1998cited by this paper
• Relationship of compliance with hormone replacement therapy to short-term healthcare utilization in a managed care population.

  1998cited by this paper
• Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization.

  1998cited by this paper
• Applications of health risk adjustment: what can be learned from experience to date?

  1998cited by this paper
• Relationship of compliance with hormone replacement therapy to short-term healthcare utilization in a managed care population.

  1998cited by this paper
• Applications of health risk adjustment: what can be learned from experience to date?

  1998cited by this paper
• Use of services by diabetes patients in managed care organizations. Development of a diabetes surveillance system. CDC Diabetes in Managed Care Work Group.

  1998cited by this paper
• Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. Bethesda, Maryland, August 29-31, 1995.

  1997cited by this paper
• Fixing Medicare.

  1997cited by this paper
• Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data.

  1997cited by this paper
• The Medicare-HMO revolving door--the healthy go in and the sick go out.

  1997cited by this paper
• Methods for Comparison of Cost Data

  1997cited by this paper
• Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease.

  1997cited by this paper
• Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission.

  1996cited by this paper
• Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

  1996cited by this paper
• Current estimates from the National Health Interview Survey, 1994.

  1995cited by this paper
• Seven chronic conditions: their impact on US adults' activity levels and use of medical services.

  1995cited by this paper
• Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

  1995cited by this paper
• Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1

  1994cited by this paper
• The American health care system--Medicaid.

  1993cited by this paper
• Trends in Medicare payments in the last year of life.

  1993cited by this paper
• The health benefits of smoking cessation.

  1990cited by this paper
• Accuracy of diagnostic coding for Medicare patients under the prospective-payment system.

  1988cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Survey research in New Mexico Hispanics: some methodological issues.

  1983cited by this paper
• Respiratory disease in a New Mexico population sample of Hispanic and non-Hispanic whites.

  1982cited by this paper
• Epidemiology Standardization Project (American Thoracic Society).

  1978cited by this paper
• International classification of diseases: ninth revision.

  1978cited by this paper
• Physicians' Current Procedural Terminology.

  1973cited by this paper
• Estimation of Relationships for Limited Dependent Variables

  1958cited by this paper

• Evaluation of Medical Comorbidities in Chronic Obstructive Pulmonary Disease Patients and its Impact on Outcomes in a Tertiary Care Hospital

  2026cites this paper
• Medication Non-adherence in Older Adults: Underlying Factors, Potential Interventions and Outcomes

  2025cites this paper
• Metformin in the treatment of chronic renal disease

  2025cites this paper
• Association between multimorbidity and disability among elderly with chronic obstructive pulmonary disease in Shanghai, China: a cross-sectional study

  2025cites this paper
• The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: A systematic review and meta-analysis

  2025cites this paper
• The Impact of Chronic Obstructive Pulmonary Disease on Immune Checkpoint Inhibitor Effectiveness in Non-small Cell Lung Cancer: A Population Health Study

  2025cites this paper
• Effects of long-term oxygen therapy on acute exacerbation and hospital burden: the national DISCOVERY study

  2025cites this paper
• Comorbidities of Chronic Obstructive Pulmonary Disease – An Observational Case–Control Study

  2024cites this paper
• Acute chest syndrome and coronavirus disease may be genetically determined exaggerated immune response syndromes in capillaries all over the body

  2024cites this paper
• Factors contributing to hospitalization expenditures for patients with COPD in Yunnan Province, China: a path analysis

  2024cites this paper
• Red Blood Cell supports prolong the Survival in Sickle Cell Diseases

  2023cites this paper
• Health‐care utilization among dementia patients with or without comorbid depression in Taiwan: A nationwide population‐based longitudinal study

  2023cites this paper
• Sickle Cell Diseases May Show Terminal Consequences of the Metabolic Syndrome in Much Earlier Ages

  2023cites this paper
• Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease Discharged from Coronavirus 2019 Hospitalization

  2023cites this paper
• Comorbidities and mortality among patients with chronic obstructive pulmonary disease

  2023cites this paper
• Exclusive breastfeeding for the first six months after birth: A cross-sectional study in health care centers in Khartoum, Sudan

  2023cites this paper
• As a good prognostic sign, Autosplenectomy is higher in females in Sickle Cell Diseases

  2023influential citation
• Red blood cell transfusions may have the stongest analgesic effect during acute painful crises in sickle cell diseases

  2023cites this paper
• Male Gender alone may be a bad Prognostic Factor in Sickle Cell Diseases

  2023cites this paper
• Multidisciplinary Care and Prognosis in Patients With COPD and Interstitial Lung Disease Prescribed Long-Term Oxygen Therapy

  2022cites this paper
• Acute chest syndrome and pulmonary hypertension in sickle cell diseases

  2022cites this paper
• Healthcare costs of patients with chronic obstructive pulmonary disease in Denmark – specialist care versus GP care only

  2022cites this paper
• PREVALENCE OF CARDIOVASCULAR COMORBIDITIES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SUBURBAN AREAS OF SOUTH-WEST INDIA

  2022cites this paper
• Pulmonary hypertension and chronic obstructive pulmonary disease in sickle cell diseases

  2022cites this paper
• Post tuberculosis chronic lung disease in tuberculosis HIV coinfected and non-HIV individuals in Sub-Saharan Africa: A systematic review and meta-analysis

  2022cites this paper
• Co-Occurring Depression and Associated Healthcare Utilization and Expenditure in Individuals with Respiratory Condition: A Population-Based Study

  2021cites this paper
• August 2021 - Volume 15, Issue 3 AUTOSPLENECTOMY MAY NOT HAVE AN ATHEROSCLEROTIC BACKGROUND IN SICKLE CELL DISEASES

  2021cites this paper
• Comorbidities in Patients With Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare system

  2021cites this paper
• A population-based analysis of spirometry use and the prevalence of chronic obstructive pulmonary disease in lung cancer

  2021cites this paper
• A fogágybetegség és a krónikus obstruktív tüdőbetegség kapcsolatának jelentősége

  2021cites this paper
• Impact of Comorbidities on the Management Outcome of Acute Exacerbation of COPD

  2021cites this paper
• Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae

  2021cites this paper
• Réhabilitation respiratoire dans la bronchopneumopathie chronique obstructive

  2021cites this paper
• Comorbidity Clusters and Healthcare Use in Individuals With COPD

  2020influential citation
• Costs of Treatment of Severe COPD Exacerbation in Serbia

  2020cites this paper
• The Impact of COPD in Trends of Urinary Tract Infection Hospitalizations in Spain, 2001–2018: A Population-Based Study Using Administrative Data

  2020cites this paper
• Influence of Comorbidities on Hospital Mortality and Healthcare Utilization in Hospitalized Chronic Obstructive Pulmonary Disease Patients

  2020cites this paper
• Immediate and Near Future Prediction of COVID-19 Patients in the U.S. Population Aged 65+ With the Prior Medical Conditions of Hypertension, Cardiovascular and Lung Diseases: Methods, Models and Acute Care Estimates

  2020cites this paper
• Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study

  2020cites this paper
• Muscle loss contributes to higher morbidity and mortality in COPD: An analysis of national trends

  2020cites this paper
• Results on health-related quality of life and functionality of a patient-centered self-management program in hospitalized COPD: a randomized control trial

  2020cites this paper
• Multimorbidity in Patients with Chronic Obstructive Pulmonary Disease.

  2020cites this paper
• Impact of tobacco-related chronic obstructive pulmonary disease on developmental trajectories of comorbidities in the Taiwan population

  2020cites this paper
• Is bilateral corticospinal connectivity impaired in patients with chronic obstructive pulmonary disease?

  2020cites this paper
• Economic outcomes among chronic obstructive pulmonary disease Vietnamese patients: Approach considerations from a social perspective.

  2019cites this paper
• Can the COPD-comorbidome Be Applied to All Outpatients With Chronic Obstructive Pulmonary Disease? A Single-center Analysis.

  2019cites this paper
• Blood biomarkers in chronic obstructive pulmonary disease (COPD)

  2019cites this paper
• Revealing Methodological Challenges in Chronic Obstructive Pulmonary Disease Studies Assessing Comorbidities: A Narrative Review.

  2019cites this paper
• Psychoactive medications in chronic obstructive pulmonary disease patients: From prevalence to effects on motor command and strength.

  2019cites this paper
• Influence of comorbidities in long-term survival of chronic obstructive pulmonary disease patients.

  2019cites this paper
• Is chronic obstructive pulmonary disease a risk factor for erectile dysfunction? A cross-sectional, comparative study

  2019cites this paper
• Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD.

  2018cites this paper
• Comorbidities in chronic obstructive pulmonary disease: Results of a national multicenter research project.

  2018cites this paper
• Risk and temporal order of disease diagnosis of comorbidities in patients with COPD: a population health perspective

  2018cites this paper
• Prevalence of osteoarthritis in individuals with COPD: a systematic review

  2018cites this paper
• Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD

  2018cites this paper
• Obstructive Sleep Apnea with Chronic Obstructive Pulmonary Disease among Medicare Beneficiaries

  2018cites this paper
• A Systems Medicine approach to multimorbidity. Towards personalised care for patients with Chronic Obstructive Pulmonary Disease

  2018cites this paper
• Health Status in Patients with COPD According to GOLD 2017 Classification: Use of the COMCOLD Score in Routine Clinical Practice

  2018cites this paper
• Atherosclerotic Background of Hepatosteatosis in Sickle Cell Diseases

  2018cites this paper
• Pathophysiology of pulmonary hypertension in sickle cell diseases

  2018cites this paper
• Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC

  2018cites this paper
• Economic burden of COPD in a Swedish cohort: the ARCTIC study

  2018cites this paper
• COPD definition by GOLD ( Global Initiative for Chronic Obstructive Lung Disease ) guidelines : 5 “ Chronic obstructive pulmonary disease

  2018influential citation
• Comorbidities: Assessment and Treatment

  2017cites this paper
• Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?

  2017cites this paper
• Excess economic burden of comorbidities in COPD: a 15-year population-based study

  2017cites this paper
• Health and Ageing in Older Adults: A gender-specific and life-course perspective

  2017cites this paper
• Atherosclerotic background of hepatomegaly, left lobe hypertrophy, and cirrhosis in sickle cell diseases

  2017cites this paper
• A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study

  2017cites this paper
• Impact of Multisystem Health Care on Readmission and Follow-up Among Veterans Hospitalized for Chronic Obstructive Pulmonary Disease

  2017cites this paper
• Sickle Cell Diseases as an Accelerated Atherosclerotic Process in Whole Body İncluding the Heart

  2017cites this paper
• Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study).

  2017cites this paper
• Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study).

  2017cites this paper
• Impact of chronic kidney disease among Korean adults with chronic obstructive pulmonary disease

  2017cites this paper
• Adherence and healthcare utilization among older adults with COPD and depression.

  2017cites this paper
• Atherosclerotic background of benign prostatic hyperplasia in sickle cell diseases

  2017cites this paper
• Explaining the link between access-to-care factors and health care resource utilization among individuals with COPD

  2016cites this paper
• Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France

  2016cites this paper
• Venous involvement in sickle cell diseases

  2016cites this paper
• Acute Chest Syndrome Does Not Have a Chronic Inflammatory Background in Sickle Cell Diseases

  2016cites this paper
• Metabolic syndrome and chronic obstructive pulmonary disease

  2016cites this paper
• New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary disease

  2016cites this paper
• Which Are The Most Relevant Comorbidities In COPD

  2016cites this paper
• Red Blood Cell Supports in Severe Clinical Conditions in Sickle Cell Diseases

  2016cites this paper
• Cardiac Biomarkers in the Identification of Future Risk in Chronic Obstructive Pulmonary Disease.

  2016cites this paper
• Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK

  2016cites this paper
• COPD related Comorbidities: From the Solar System to the Milky Way

  2016cites this paper
• Clinical factors and comorbidities affecting the cost of hospital-treated COPD

  2016influential citation
• Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.

  2016cites this paper
• Tiotropium as part of inhaled polytherapy: Adherence and associated health‐care utilization

  2015cites this paper
• A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world

  2015cites this paper
• COPD und systemische Manifestationen

  2015cites this paper
• Evaluation of C-Reactive Protein in Patients with Chronic Obstructive Pulmonary Disease

  2015cites this paper
• Is hypercapnia associated with poor prognosis in chronic obstructive pulmonary disease? A long-term follow-up cohort study

  2015cites this paper
• Managing comorbidities in COPD

  2015influential citation
• BPCO et manifestations systémiques

  2015cites this paper
• Chronic Obstructive Pulmonary Diseases : Journal of the COPD Foundation Prevalence and Comorbidities of Chronic Obstructive Pulmonary Disease Among Adults in Kentucky Across Gender and Area Development Districts , 2011

  2015cites this paper
• Chronic Obstructive Pulmonary Disease May Be One of the Terminal Endpoints of the Sickle Cell Diseases

  2015cites this paper